Our Network Large real-world evidence studies reveal disproportionate burden of COVID-19 on the immunocompromised Tags: #Research #RWE #COVID #Vaccines #AstraZeneca Data covering almost 30 million individuals show continued burden of disease; immunocompromised individuals comprise approximately one quarter of all COVID-19 hospitalisations, ICU admissions and deaths.
